433 related articles for article (PubMed ID: 15501444)
1. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility.
Wheeler AP; Ridley AJ
Exp Cell Res; 2004 Nov; 301(1):43-9. PubMed ID: 15501444
[TBL] [Abstract][Full Text] [Related]
2. RhoA, RhoB and RhoC have different roles in cancer cell migration.
Ridley AJ
J Microsc; 2013 Sep; 251(3):242-9. PubMed ID: 23488932
[TBL] [Abstract][Full Text] [Related]
3. XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC.
Arthur WT; Ellerbroek SM; Der CJ; Burridge K; Wennerberg K
J Biol Chem; 2002 Nov; 277(45):42964-72. PubMed ID: 12221096
[TBL] [Abstract][Full Text] [Related]
4. The Role of RhoA, RhoB and RhoC GTPases in Cell Morphology, Proliferation and Migration in Human Cytomegalovirus (HCMV) Infected Glioblastoma Cells.
Tseliou M; Al-Qahtani A; Alarifi S; Alkahtani SH; Stournaras C; Sourvinos G
Cell Physiol Biochem; 2016; 38(1):94-109. PubMed ID: 26741994
[TBL] [Abstract][Full Text] [Related]
5. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
6. A current overview of RhoA, RhoB, and RhoC functions in vascular biology and pathology.
Eckenstaler R; Hauke M; Benndorf RA
Biochem Pharmacol; 2022 Dec; 206():115321. PubMed ID: 36306821
[TBL] [Abstract][Full Text] [Related]
7. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.
Casteel DE; Turner S; Schwappacher R; Rangaswami H; Su-Yuo J; Zhuang S; Boss GR; Pilz RB
J Biol Chem; 2012 Nov; 287(45):38367-78. PubMed ID: 22992742
[TBL] [Abstract][Full Text] [Related]
8. Mouse macrophages completely lacking Rho subfamily GTPases (RhoA, RhoB, and RhoC) have severe lamellipodial retraction defects, but robust chemotactic navigation and altered motility.
Königs V; Jennings R; Vogl T; Horsthemke M; Bachg AC; Xu Y; Grobe K; Brakebusch C; Schwab A; Bähler M; Knaus UG; Hanley PJ
J Biol Chem; 2014 Oct; 289(44):30772-30784. PubMed ID: 25213860
[TBL] [Abstract][Full Text] [Related]
9. Differential binding of RhoA, RhoB, and RhoC to protein kinase C-related kinase (PRK) isoforms PRK1, PRK2, and PRK3: PRKs have the highest affinity for RhoB.
Hutchinson CL; Lowe PN; McLaughlin SH; Mott HR; Owen D
Biochemistry; 2013 Nov; 52(45):7999-8011. PubMed ID: 24128008
[TBL] [Abstract][Full Text] [Related]
10. Divergence of Rho residue 43 impacts GEF activity.
Sloan CM; Quinn CV; Peters JP; Farley J; Goetzinger C; Wernli M; DeMali KA; Ellerbroek SM
Small GTPases; 2012; 3(1):15-22. PubMed ID: 22673745
[TBL] [Abstract][Full Text] [Related]
11. RhoA-GDP regulates RhoB protein stability. Potential involvement of RhoGDIalpha.
Ho TT; Merajver SD; Lapière CM; Nusgens BV; Deroanne CF
J Biol Chem; 2008 Aug; 283(31):21588-98. PubMed ID: 18524772
[TBL] [Abstract][Full Text] [Related]
12. A RhoC biosensor reveals differences in the activation kinetics of RhoA and RhoC in migrating cells.
Zawistowski JS; Sabouri-Ghomi M; Danuser G; Hahn KM; Hodgson L
PLoS One; 2013; 8(11):e79877. PubMed ID: 24224016
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional and post-transcriptional regulation of the genes encoding the small GTPases RhoA, RhoB, and RhoC: implications for the pathogenesis of human diseases.
Nomikou E; Livitsanou M; Stournaras C; Kardassis D
Cell Mol Life Sci; 2018 Jun; 75(12):2111-2124. PubMed ID: 29500478
[TBL] [Abstract][Full Text] [Related]
14. Loss of RhoA promotes skin tumor formation and invasion by upregulation of RhoB.
García-Mariscal A; Li H; Pedersen E; Peyrollier K; Ryan KM; Stanley A; Quondamatteo F; Brakebusch C
Oncogene; 2018 Feb; 37(7):847-860. PubMed ID: 29059167
[TBL] [Abstract][Full Text] [Related]
15. A p27(kip1)-binding protein, p27RF-Rho, promotes cancer metastasis via activation of RhoA and RhoC.
Hoshino D; Koshikawa N; Seiki M
J Biol Chem; 2011 Jan; 286(4):3139-48. PubMed ID: 21087931
[TBL] [Abstract][Full Text] [Related]
16. RhoA, RhoB and RhoC differentially regulate endothelial barrier function.
Pronk MCA; van Bezu JSM; van Nieuw Amerongen GP; van Hinsbergh VWM; Hordijk PL
Small GTPases; 2019 Nov; 10(6):466-484. PubMed ID: 28949796
[TBL] [Abstract][Full Text] [Related]
17. RhoB as a tumor suppressor: It's all about localization.
Zaoui K; Duhamel S
Eur J Cell Biol; 2023 Jun; 102(2):151313. PubMed ID: 36996579
[TBL] [Abstract][Full Text] [Related]
18. RhoA and RhoC are both required for the ROCK II-dependent promotion of centrosome duplication.
Kanai M; Crowe MS; Zheng Y; Vande Woude GF; Fukasawa K
Oncogene; 2010 Nov; 29(45):6040-50. PubMed ID: 20697357
[TBL] [Abstract][Full Text] [Related]
19. Effects of lovastatin on Rho isoform expression, activity, and association with guanine nucleotide dissociation inhibitors.
Turner SJ; Zhuang S; Zhang T; Boss GR; Pilz RB
Biochem Pharmacol; 2008 Jan; 75(2):405-13. PubMed ID: 17920041
[TBL] [Abstract][Full Text] [Related]
20. DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms.
Healy KD; Hodgson L; Kim TY; Shutes A; Maddileti S; Juliano RL; Hahn KM; Harden TK; Bang YJ; Der CJ
Mol Carcinog; 2008 May; 47(5):326-37. PubMed ID: 17932950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
